Drugs Containing Excipient (Inactive Ingredient) POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER

Branded drugs containing POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Braintree Laboratories Inc	SUTAB	sodium sulfate, magnesium sulfate, and potassium chloride	52268-201	POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER	2037-08-04
Janssen Biotech Inc	ICOTYDE	icotrokinra	57894-201	POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER	2039-07-12
BridgeBio Pharma Inc	ATTRUBY	acoramidis hydrochloride	82228-712	POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER	2039-08-16
KalVista Pharmaceuticals Ltd	EKTERLY	sebetralstat	82928-300	POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER	2035-11-26

Generic drugs containing POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER excipient

Company	Ingredient	NDC	Excipient
Lannett Company Inc	venlafaxine hydrochloride	0527-2604	POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
Lannett Company Inc	venlafaxine	0527-2606	POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
Par Pharmaceutical Inc	propafenone hydrochloride	0603-5448	POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER
NCS HealthCare of KY LLC dba Vangard Labs	omeprazole	0615-8406	POLYVINYL ALCOHOL GRAFT POLYETHYLENE GLYCOL COPOLYMER

Market Dynamics and Financial Trajectory for Polyvinyl Alcohol Graft Polyethylene Glycol Copolymer

Last updated: February 20, 2026

What is the Current Market Environment?

Polyvinyl alcohol (PVOH) graft polyethylene glycol (PEG) copolymer is an excipient used primarily in drug delivery systems, medical devices, and cosmetic formulations. Its unique properties include water solubility, biocompatibility, and controlled-release capabilities, driving demand across pharmaceutical and biotech segments.

The global market for graft copolymers like PVOH-PEG is expanding at an annual compound growth rate (CAGR) of approximately 6% (2023–2028). The pharmaceutical segment accounts for 70% of this market, with the remainder in personal care and industrial applications.

Key industry drivers include increased demand for targeted drug delivery systems, advances in biodegradable materials, and rising R&D investments in biomaterials. The Asia-Pacific region leads growth, fueled by China and India, which emphasize healthcare access and biotechnology development.

Market Size and Revenue Estimates

As of 2023, the global graft copolymer market was valued at approximately USD 1.2 billion. PVOH-PEG copolymer, forming a niche segment within this market, is estimated to generate USD 250 million annually, with projections reaching USD 340 million by 2028.

Table 1. Market Revenue Estimates (USD millions)

Year	Market Value	CAGR	Notes
2023	250	6%	Base estimate for PVOH-PEG copolymer
2025	290
2028	340

Key Market Segments and Applications

• Pharmaceuticals: Controlled-release formulations, bioadhesive drug delivery systems.
• Medical Devices: Coatings, biocompatible matrices.
• Cosmetics: Moisturizers, film-forming agents.
• Industrial: Water treatment, biodegradable materials.

The pharmaceutical sector dominates due to the copolymer’s biocompatibility and functional versatility.

Competitive Landscape

Major players include:

• BASF: Provides graft copolymer specialties for medical and pharmaceutical applications.
• Kuraray: Supplies PVOH-based excipients integrated with PEG modifications.
• Wacker Chemie: Focuses on biocompatible polymers for controlled-release systems.
• LG Chem: Develops novel copolymer formulations for drug delivery.

Emerging biotech firms and custom polymer developers are channeling investments toward biodegradable and non-toxic copolymers, increasing competition.

Regulatory and Policy Environment

Global regulatory agencies, including the US FDA and EMA, regulate excipients to ensure safety and efficacy. The increasing scrutiny for biocompatibility and environmental impact influences product development.

In 2022, the FDA issued guidance emphasizing biopolymer excipients' quality. This has led to heightened regulatory compliance costs but also underscores market stability for compliant manufacturers.

R&D and Innovation Trends

• Functionalization: Incorporating targeting ligands into PVOH-PEG copolymers.
• Biodegradability: Developing environmentally degradable formulations.
• Stimuli-responsive systems: Engineering polymers that respond to pH, temperature, or enzymes.

Investment in R&D by pharmaceutical firms and university research grants supports ongoing innovation.

Financial Outlook and Investment Implications

Projected revenue growth aligns with industry CAGR estimates, driven by increased adoption in advanced drug formulations. Capital expenditure on R&D and capacity expansion should sustain growth.

Investors should focus on:

• Companies with proprietary graft copolymer technologies.
• Firms with scalable manufacturing processes.
• Firms with strong regulatory compliance records.

Risks and Challenges

• Regulatory hurdles: Stringent approval processes can delay product launches.
• Market fragmentation: Numerous small players can lead to price pressures.
• Supply chain disruptions: Raw material availability impacts production.

Conclusion

The PVOH-PEG graft copolymer excipient market is poised for steady growth over the next five years, supported by pharmaceutical innovation, regulatory environments favoring biocompatible materials, and technological advancements.

---

Key Takeaways

• The market size for PVOH-PEG graft copolymers is approximately USD 250 million in 2023, with a 6% CAGR projected through 2028.
• Pharmaceutical applications dominate, particularly in controlled-release drug delivery.
• Leading companies include BASF, Kuraray, and Wacker Chemie, with increasing competition from biotech startups.
• Regulatory advancements emphasize safety and environmental impact, influencing product development.
• R&D initiatives focus on biofunctionality, biodegradability, and stimuli-responsive systems.

---

FAQs

1. What are the primary applications of PVOH-PEG graft copolymers?
Mainly used in controlled-release drug formulations, medical device coatings, and cosmetic products due to their biocompatibility and water solubility.

2. Which regions drive the most demand?
The Asia-Pacific region, particularly China and India, leads demand, owing to expanding healthcare infrastructure and biotech research.

3. What are the key regulatory considerations?
Regulatory agencies require safety, biocompatibility, and environmental impact assessments, leading to stricter approval processes.

4. Who are the leading manufacturers?
BASF, Kuraray, and Wacker Chemie dominate the market, with newer entrants focusing on biodegradable and stimuli-responsive variants.

5. What are the main risks for market growth?
Regulatory delays, market fragmentation, and raw material supply chain disruptions pose risks to growth trajectories.

---

References

[1] MarketsandMarkets. (2023). Graft Copolymer Market by Type, Application, and Region: Global Forecast to 2028. Retrieved from https://www.marketsandmarkets.com